Navigation Links
Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:5/7/2009

e to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Cadence(TM), Acetavance(TM) and Omigard(TM) are trademarks of Cadence Pharmaceuticals, Inc.

    Contacts:   William R. LaRue
                SVP & Chief Financial Officer
                Cadence Pharmaceuticals, Inc.
                858-436-1400

                          CADENCE PHARMACEUTICALS, INC.
                          (a development stage company)
                       CONDENSED STATEMENTS OF OPERATIONS
                                  (unaudited)

                                                  Three Months Ended
                                                        March 31,
                                                  2009            2008
    Operating expenses:
      Research and development                $6,139,342    $10,478,047
      Marketing                                  536,115        583,702
      General and administrative               2,811,747      2,667,038
      Other                                      650,786         28,257
        Total operating expenses              10,137,990     13,757,044

    Loss from operations                     (10,137,990)   (13,757,044)

    Other (expense) income, net                 (299,373)        40,129

    Net loss                                $(10,437,363)  $(13,716,915)

    Basic and diluted net loss per share(1)       $(0.24)        $(0.42)

    Shares used to compute basic and
    diluted net loss per share(1)             43,831,889     32,921,093

    (1) As a result of the issuance of 12,039,794 shares of common stock
        pursuant to a private placement in the first quarter of 2009 and
        9,240,307 shares of common stock pursuant to an effective shelf
        registration in the first qu
'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009
2. Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
3. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2008 Financial Results and Corporate Update on March 12, 2009
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and Provide a Clinical Program Update on November 6, 2008
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIOCOM Investor Conference
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
11. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... The winners of awards for supply chain resilience ... Global Supply Chain Resiliency Council (GSCRC) at the ... 25th, 2015, at the Hyatt Regency in Santa Clara, ... supply chain risk management and resiliency practitioners with luminaries ... opportunities to collaborate, develop and share best practices, and ...
(Date:3/3/2015)... March 3, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... scientific journal, Expert Opinion on Biological Therapy , ... Zhenggang Zhang , at the Henry Ford Hospital ... Thymosin beta 4 (TB4) has the capacity to promote ... or more post-injury, leading to neurological recovery in each ...
(Date:3/3/2015)... 3, 2015  Rosa & Co. LLC, a drug ... simulation research, today announced it has two posters scheduled ... Clinical Pharmacology and Therapeutics meeting in New ... Logo - http://photos.prnewswire.com/prnh/20150302/179058LOGO   ... poster describing a quantitative systems pharmacology approach for immuno-oncology ...
(Date:3/3/2015)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a ... pets, announced today that it will release its fourth quarter ... the market close. The Company will host a conference call ... Interested parties may access the call by dialing toll-free (855) ... conference ID 98449349.  The call will also ...
Breaking Biology Technology:Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3
... basement at Menasha Advantage, a subsidiary of Neenahs Menasha ... The Skunkworks. There, a better cardboard box is being ... Menasha Advantage is building a system to track shipments ... The Internet-based system will save time, money and headaches ...
... , ,Identity theft has seen the largest increase in any ... States is faced with an ever-changing and creative criminal. ... equation, organizational and consumer. , ,Identity theft tops ... from the Federal Trade Commission (FTC). Based on the ...
... in Games Apply to Academics , ,MADISON-WI. - ... , a University of Wisconsin-Madison researcher about his work ... learning a game can be used in academics. ... University of Wisconsin-Madison to continue his research on games ...
Cached Biology Technology:E-Commerce Skunkworks in Menhasa 2E-Commerce Skunkworks in Menhasa 3Are You Ready for Identity Theft? 2Are You Ready for Identity Theft? 3Are You Ready for Identity Theft? 4Are You Ready for Identity Theft? 5Are You Ready for Identity Theft? 6Are You Ready for Identity Theft? 7GameBased Learning Strategies 2GameBased Learning Strategies 3
(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
(Date:2/5/2015)...  It is gratifying to see that the Obama ... science as a means to better understand human biology, ... was honored to participate in today,s White House event ... Since the 1980s my teams have been ... sequenced genome of a free living organism, the first ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the ... report to their offering. , The ... individual is who she/he is claiming to be, and for ... unique physical characteristics, such as fingerprint, hand or palm print, ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... killing tumours in what they hope could one day lead ... Manchester research has identified a key gene that appears to ... division. Cells divide creating new cells as part of ... results when cells divide in an uncontrolled way. What ...
... into the body to reverse learning problems in mice that ... researchers have found. The protein -- part of the ... onto the amyloid beta protein in the brain and prevents ... Alzheimers disease. Our research in an animal model showed ...
... Here is the latest American Chemical Society (ACS) News ... journals and Chemical & Engineering News.,Please credit the individual ... for this information. , ARTICLE #1 FOR ... biofactories, Biotechnology Progress Scientists are reporting an advance ...
Cached Biology News:Gene may hold key to future cancer hope 2American Chemical Society's Weekly PressPac -- Oct. 3, 2007 2American Chemical Society's Weekly PressPac -- Oct. 3, 2007 3American Chemical Society's Weekly PressPac -- Oct. 3, 2007 4American Chemical Society's Weekly PressPac -- Oct. 3, 2007 5American Chemical Society's Weekly PressPac -- Oct. 3, 2007 6American Chemical Society's Weekly PressPac -- Oct. 3, 2007 7American Chemical Society's Weekly PressPac -- Oct. 3, 2007 8